Association between penicillin allergy documentation and antibiotic use

Kimberly G. Blumenthal; Kristi Kuper; Lucas T. Schulz; Tanaya Bhowmick; Michael Postelnick; Francesca Lee; Rochelle P. Walensky

doi:10.1001/jamainternmed.2020.2227

Association between penicillin allergy documentation and antibiotic use

Kimberly G. Blumenthal, Kristi Kuper, Lucas T. Schulz, Tanaya Bhowmick, Michael Postelnick, Francesca Lee, Rochelle P. Walensky

Research output: Contribution to journal › Letter › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	1120-1122
Number of pages	3
Journal	JAMA Internal Medicine
Volume	180
Issue number	8
DOIs	https://doi.org/10.1001/jamainternmed.2020.2227
State	Published - Aug 2020

ASJC Scopus subject areas

Internal Medicine

Access to Document

10.1001/jamainternmed.2020.2227

Cite this

@article{c327b4fb80e94cafafce13bf06ba00c0,

title = "Association between penicillin allergy documentation and antibiotic use",

author = "Blumenthal, {Kimberly G.} and Kristi Kuper and Schulz, {Lucas T.} and Tanaya Bhowmick and Michael Postelnick and Francesca Lee and Walensky, {Rochelle P.}",

note = "Funding Information: Published Online: June 29, 2020. doi:10.1001/jamainternmed.2020.2227 Author Contributions: Dr Blumenthal had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: All authors. Acquisition, analysis, or interpretation of data: Blumenthal, Kuper, Schulz, Postelnick, Lee, Walensky. Drafting of the manuscript: Blumenthal, Lee. Critical revision of the manuscript for important intellectual content: Blumenthal, Kuper, Schulz, Bhowmick, Postelnick, Walensky. Statistical analysis: Blumenthal, Lee. Obtained funding: Blumenthal. Administrative, technical, or material support: Blumenthal, Kuper, Schulz, Walensky. Supervision: Schulz, Bhowmick, Walensky. Conflict of Interest Disclosures: Dr Blumenthal reported intellectual property for a clinical decision support tool used institutionally for β-lactam allergy assessment at Partners HealthCare System, which is licensed to Persistent Systems. Dr Kuper reported being an employee of Vizient Inc at the time of the study. Dr Lee reported receiving grants from Lynntech outside the submitted work. No other disclosures were reported. Funding/Support: Dr Blumenthal was supported by a career development grant (K01AI125631) from the National Institutes of Health; the American Academy of Allergy, Asthma, and Immunology Foundation; and the Massachusetts General Hospital Claflin Distinguished Scholar Award. Dr Walensky was supported by the Steven and Deborah Gorlin Massachusetts General Hospital Research Scholars Award.",

year = "2020",

month = aug,

doi = "10.1001/jamainternmed.2020.2227",

language = "English (US)",

volume = "180",

pages = "1120--1122",

journal = "JAMA Internal Medicine",

issn = "2168-6106",

publisher = "American Medical Association",

number = "8",

}

TY - JOUR

T1 - Association between penicillin allergy documentation and antibiotic use

AU - Blumenthal, Kimberly G.

AU - Kuper, Kristi

AU - Schulz, Lucas T.

AU - Bhowmick, Tanaya

AU - Postelnick, Michael

AU - Lee, Francesca

AU - Walensky, Rochelle P.

N1 - Funding Information: Published Online: June 29, 2020. doi:10.1001/jamainternmed.2020.2227 Author Contributions: Dr Blumenthal had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. Concept and design: All authors. Acquisition, analysis, or interpretation of data: Blumenthal, Kuper, Schulz, Postelnick, Lee, Walensky. Drafting of the manuscript: Blumenthal, Lee. Critical revision of the manuscript for important intellectual content: Blumenthal, Kuper, Schulz, Bhowmick, Postelnick, Walensky. Statistical analysis: Blumenthal, Lee. Obtained funding: Blumenthal. Administrative, technical, or material support: Blumenthal, Kuper, Schulz, Walensky. Supervision: Schulz, Bhowmick, Walensky. Conflict of Interest Disclosures: Dr Blumenthal reported intellectual property for a clinical decision support tool used institutionally for β-lactam allergy assessment at Partners HealthCare System, which is licensed to Persistent Systems. Dr Kuper reported being an employee of Vizient Inc at the time of the study. Dr Lee reported receiving grants from Lynntech outside the submitted work. No other disclosures were reported. Funding/Support: Dr Blumenthal was supported by a career development grant (K01AI125631) from the National Institutes of Health; the American Academy of Allergy, Asthma, and Immunology Foundation; and the Massachusetts General Hospital Claflin Distinguished Scholar Award. Dr Walensky was supported by the Steven and Deborah Gorlin Massachusetts General Hospital Research Scholars Award.

PY - 2020/8

Y1 - 2020/8

UR - http://www.scopus.com/inward/record.url?scp=85088090939&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85088090939&partnerID=8YFLogxK

U2 - 10.1001/jamainternmed.2020.2227

DO - 10.1001/jamainternmed.2020.2227

M3 - Letter

C2 - 32597920

AN - SCOPUS:85088090939

VL - 180

SP - 1120

EP - 1122

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 8

ER -